Education
About Us
Working with TipRanks
Follow Us
Praxis Precision Medicines (PRAX)
NASDAQ:PRAX
Earnings Data
Report Date
Nov 05, 2025Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
-3.37Last Year’s EPS
-2.75Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call for Praxis Precision Medicine was predominantly positive, with significant achievements in clinical trial results, particularly for vormatrigine, which demonstrated best-in-disease efficacy. The company also highlighted strong recruitment capabilities and potential mood benefits from its treatments. However, the high discontinuation rate in the RADIANT study was noted as a challenge.Company Guidance -
Q3 2025
Best-in-Disease Efficacy for Vormatrigine
Vormatrigine showed best-in-disease efficacy in the RADIANT study, with a median seizure reduction of over 56%. Importantly, 60% of patients achieved at least a 50% reduction in seizures, and over 22% of patients were completely seizure-free during the second month of treatment.
Strong Recruitment and Execution
The RADIANT study exceeded its enrollment target, demonstrating effective recruitment capabilities. Praxis also has a cash runway extending into 2028, supporting its ambitious clinical agenda.
Potential Mood Benefits
Patients reported positive impacts on mood during the RADIANT study, prompting Praxis to include depression and mood endpoints in the POWER2 study design.
PRAX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PRAX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 04, 2025 | $54.09 | $51.09 | -5.55% |
May 02, 2025 | $38.06 | $40.24 | +5.73% |
Feb 28, 2025 | $65.03 | $38.60 | -40.64% |
Nov 06, 2024 | $72.73 | $71.87 | -1.18% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Praxis Precision Medicines (PRAX) report earnings?
Praxis Precision Medicines (PRAX) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).
What is Praxis Precision Medicines (PRAX) earnings time?
Praxis Precision Medicines (PRAX) earnings time is at Nov 05, 2025, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRAX EPS forecast?
PRAX EPS forecast for the fiscal quarter 2025 (Q3) is -3.37.